← Back to headlines
Medpace stock falls despite Q1 earnings beat
Medpace shares declined even after the company reported better-than-expected Q1 earnings, with its 2026 guidance ranges including consensus estimates.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
